FDA revises judgments made on products containing ozone-depleting substances
ROCKVILLE, Md. The Food and Drug Administration issued a final rule earlier this month that amends the agency’s regulation on the use of ozone-depleting substances in self-pressurized containers—the over-the-counter asthma symptom reliever epinephrine no longer has “essential use” designation.
“After consulting with the U.S. Environmental Protection Agency, FDA says it has determined that there are no substantial technical barriers to formulating epinephrine as a product that does not release ODSs. Therefore, the agency has concluded that epinephrine would no longer be an essential use of ODSs,” the Consumer Healthcare Products Association stated in its newsletter Wednesday.
Manufacturers have until Dec. 31, 2011 to discontinue distribution of epinephrine inhalers that emit ODSs.
NAD recommends Nutrition 21 end claims its supplement aids memory
NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Tuesday recommended that Nutrition 21, the marketer of Core4Life Advanced Memory Formula, discontinue with claims that its supplement improves memory.
Specifically, NAD challenged Nutrition 21’s “unqualified claims” that Advanced Memory Formula “Improves Memory & Recall,” “Increases Alertness & Concentration” and “Helps Improve Focus and Vitality.” These claims were not supported by the evidence, NAD asserted, and should be discontinued or modified to more accurately reflect the existing evidence.
Nutrition 21 appreciates “NAD’s careful consideration in making its decision and agrees to take the NAD’s conclusions and recommendations in this matter into account in future advertising of its Core4Life Advanced Memory Formula product,” the company said.
Tylenol Warming Liquids promotional taxis ferry customers free of charge
PHILADELPHIA McNeil Consumer Healthcare on Monday relocated its Tylenol Warming Taxies from Boston—the taxies will be picking passengers up free-of-charge in front of select CVS/pharmacy locations Dec. 1-7.
The makers of Tylenol Warming Liquids have embarked on a multi-city tour offering passengers access to free taxi rides so they can warm up. The guerilla marketing tactic has already proven a success in New York and Boston, and will be moving to Washington following its tour through Philadelphia.